The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The therapeutic potential of bilobalide on experimental autoimmune encephalomyelitis (EAE) mice
Authors
Keywords
-
Journal
METABOLIC BRAIN DISEASE
Volume 35, Issue 5, Pages 793-807
Publisher
Springer Science and Business Media LLC
Online
2020-03-25
DOI
10.1007/s11011-020-00555-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- By Activating Akt/eNOS Bilobalide B Inhibits Autophagy and Promotes Angiogenesis Following Focal Cerebral Ischemia Reperfusion
- (2018) Yongqiu Zheng et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Multiple Sclerosis
- (2018) Daniel S. Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation
- (2018) Francesca Romana Rizzo et al. NEURAL PLASTICITY
- Human pharmacokinetics of ginkgo terpene lactones and impact of carboxylation in blood on their platelet-activating factor antagonistic activity
- (2018) Xin-wei Liu et al. ACTA PHARMACOLOGICA SINICA
- Meningeal inflammation and cortical demyelination in acute multiple sclerosis
- (2018) Ryan J. Bevan et al. ANNALS OF NEUROLOGY
- Protective and therapeutic role of Bilobalide in cuprizone-induced demyelination
- (2018) Ruo-Xuan Sui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- T cells take aim at a ubiquitous autoantigen in multiple sclerosis
- (2018) Joseph J. Sabatino et al. Science Translational Medicine
- Effects of bilobalide, ginkgolide B and picrotoxinin on GABA A receptor modulation by structurally diverse positive modulators
- (2017) Chiu Chin Ng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function
- (2017) Daniel Ontaneda et al. LANCET
- Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair
- (2017) Yuan Zhang et al. MOLECULAR THERAPY
- The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord
- (2017) Arathi Jayaraman et al. NEUROBIOLOGY OF DISEASE
- Ginkgolides and bilobalide protect BV2 microglia cells against OGD/reoxygenation injury by inhibiting TLR2/4 signaling pathways
- (2016) Jian-Ming Zhou et al. CELL STRESS & CHAPERONES
- Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis
- (2016) Roland Martin et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The effect of B-cell depletion in the Theiler's model of multiple sclerosis
- (2015) Francesca Gilli et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The re-emergence of antigen-specific tolerance as a potential therapy for MS
- (2015) Lawrence Steinman Multiple Sclerosis Journal
- The re-emergence of antigen-specific tolerance as a potential therapy for MS
- (2015) Lawrence Steinman Multiple Sclerosis Journal
- Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process
- (2014) M Bonora et al. CELL DEATH AND DIFFERENTIATION
- Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages
- (2014) Chun-Yun Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis
- (2014) Zhilong Jiang et al. IMMUNOLOGY LETTERS
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
- (2014) Navneet Singh et al. Journal of Neuroinflammation
- Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
- (2014) Dean M. Wingerchuk et al. MAYO CLINIC PROCEEDINGS
- Pharmacogenomics of interferon beta and glatiramer acetate response: A review of the literature
- (2013) Sunil Mahurkar et al. AUTOIMMUNITY REVIEWS
- Antigen-specific tolerization approaches in multiple sclerosis
- (2013) Andreas Lutterotti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Protective effect of bilobalide on learning and memory impairment in rats with vascular dementia
- (2013) WEI-ZU LI et al. Molecular Medicine Reports
- Protective effects of bilobalide on Aβ25–35 induced learning and memory impairments in male rats
- (2013) Yanyan Yin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology
- (2013) Conor Mc Guire et al. TRENDS IN MOLECULAR MEDICINE
- Intestinal Absorption and Presystemic Elimination of Various Chemical Constituents Present in GBE50 Extract, a Standardized Extract of Ginkgo biloba Leaves
- (2012) Li Li et al. CURRENT DRUG METABOLISM
- Inflammatory Cortical Demyelination in Early Multiple Sclerosis
- (2011) Claudia F. Lucchinetti et al. NEW ENGLAND JOURNAL OF MEDICINE
- Astrocytes promote TNF-mediated toxicity to oligodendrocyte precursors
- (2010) SunJa Kim et al. JOURNAL OF NEUROCHEMISTRY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex
- (2009) Rossana Rossi et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- IL-12/IFN-γ/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis
- (2007) Bao-Guo Xiao et al. MOLECULAR IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started